A Registered Cohort Study on Brain Calcification
1 other identifier
observational
2,000
1 country
1
Brief Summary
Brain calcification is a common neuroimaging feature in patients with metabolic, neurological, or developmental disorders, infectious diseases, traumatic or toxic history, as well as in otherwise normal older people. To understand the clinical and genetic characteristics of brain calcification, we establish a cohort of brain calcification to follow up patients with brain calcification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2019
CompletedFirst Posted
Study publicly available on registry
July 8, 2019
CompletedStudy Start
First participant enrolled
August 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2079
September 23, 2019
September 1, 2019
10.4 years
July 4, 2019
September 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of hereditary brain calcification
Look for the causative gene in the patient with brian calcification
Up to 20 years
Eligibility Criteria
Brain calcification patients who are diagnosed in the First Affiliated Hospital of Fujian Medical University
You may qualify if:
- Patients with brain calcium deposit(s) based on examinations of CT scans
- Patients with total calcification score(TCS) greater than the physiological threshold
- Relatives of brain calcification patients.
- Unrelated healthy controls
- Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process
You may not qualify if:
- Brain calcification caused by specific secondary factors such as infection, poisoning, and trauma
- Participants declining or unable to comply with trial procedures and visit schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wan-Jin Chenlead
- Taipei Veterans General Hospital, Taiwancollaborator
- Chang Gung Memorial Hospitalcollaborator
Study Sites (1)
Department of Neurology, First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, 350005, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- The Vice-Director for the Department of Neurology
Study Record Dates
First Submitted
July 4, 2019
First Posted
July 8, 2019
Study Start
August 25, 2019
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2079
Last Updated
September 23, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share